Literature DB >> 25015531

Pairwise binding competition experiments for sorting hub-protein/effector interaction hierarchy and simultaneous equilibria.

Enrico Ravera, Azzurra Carlon, Giacomo Parigi.   

Abstract

NMR experiments on proteins in simultaneous equilibria with multiple binding partners can provide a tool to understand complex biological interaction networks. Competition among proteins for binding to signaling hubs is often at the basis of the information transmission across signaling networks in every organism. Changes in affinity towards one or more partners, as well as changes of the relative concentration of the competing partners, can determine pathways alterations that lead to pathological consequences. Overall, the knowledge of the interaction hierarchy of the multiple partners to a single signaling hub can lead to new therapeutic strategies. Smith and Ikura (Nat Chem Biol 10:223–230, 2014) have recently proposed pairwise competition NMR experiments to determine the binding hierarchy in network interactions. We have taken the moves from their approach to show how from pairwise competition NMR experiments the ratios between the equilibrium constants for multiple binding partners can be determined, and thus, given their concentration in solution, the concentrations of all the possible complexes can be obtained.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25015531     DOI: 10.1007/s10858-014-9846-y

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  15 in total

Review 1.  Ras protein signalling.

Authors:  M F Olson; R Marais
Journal:  Semin Immunol       Date:  2000-02       Impact factor: 11.130

2.  Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.

Authors:  Pablo Rodriguez-Viciana; Celine Sabatier; Frank McCormick
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

3.  Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexes.

Authors:  Marc Nazaré; Hans Matter; David W Will; Michael Wagner; Matthias Urmann; Jörg Czech; Herman Schreuder; Armin Bauer; Kurt Ritter; Volkmar Wehner
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-21       Impact factor: 15.336

4.  Entropic contribution to the linking coefficient in fragment based drug design: a case study.

Authors:  Valentina Borsi; Vito Calderone; Marco Fragai; Claudio Luchinat; Niko Sarti
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

Review 5.  Reconstruction of cellular signalling networks and analysis of their properties.

Authors:  Jason A Papin; Tony Hunter; Bernhard O Palsson; Shankar Subramaniam
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

6.  Combining in silico tools and NMR data to validate protein-ligand structural models: application to matrix metalloproteinases.

Authors:  Ivano Bertini; Marco Fragai; Andrea Giachetti; Claudio Luchinat; Massimiliano Maletta; Giacomo Parigi; Kwon Joo Yeo
Journal:  J Med Chem       Date:  2005-12-01       Impact factor: 7.446

7.  Integrated RAS signaling defined by parallel NMR detection of effectors and regulators.

Authors:  Matthew J Smith; Mitsuhiko Ikura
Journal:  Nat Chem Biol       Date:  2014-01-19       Impact factor: 15.040

Review 8.  GTPase activating proteins: structural and functional insights 18 years after discovery.

Authors:  K Scheffzek; M R Ahmadian
Journal:  Cell Mol Life Sci       Date:  2005-12       Impact factor: 9.261

Review 9.  Signalling ballet in space and time.

Authors:  Boris N Kholodenko; John F Hancock; Walter Kolch
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06       Impact factor: 94.444

Review 10.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.